A detailed history of Briaud Financial Planning, Inc transactions in Amgen Inc stock. As of the latest transaction made, Briaud Financial Planning, Inc holds 815 shares of AMGN stock, worth $237,295. This represents 0.09% of its overall portfolio holdings.

Number of Shares
815
Previous 606 34.49%
Holding current value
$237,295
Previous $188,000 20.74%
% of portfolio
0.09%
Previous 0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 30, 2025

BUY
$262.28 - $309.85 $54,816 - $64,758
209 Added 34.49%
815 $227,000
Q1 2025

May 09, 2025

BUY
$258.59 - $327.36 $130,846 - $165,644
506 Added 506.0%
606 $188,000
Q1 2024

May 03, 2024

BUY
$268.87 - $324.56 $26,887 - $32,456
100 New
100 $29,000
Q3 2023

Nov 03, 2023

BUY
$218.65 - $271.46 $21,865 - $27,145
100 New
100 $26,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $156B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Briaud Financial Planning, Inc Portfolio

Follow Briaud Financial Planning, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Briaud Financial Planning, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Briaud Financial Planning, Inc with notifications on news.